Coronavirus

Views & Analysis

Coronavirus pharma news roundup – 24/07/20

With coronavirus vaccine trials finally showing positive results, analysts are starting to wonder what access challenges might lie ahead.

News

Influential MPs 'astonished' at UK government's delayed pand...

As the UK’s economy is hit by its worst contraction for 41 years, an influential committee of MPs has blasted the government’s failure to plan for the economic impact of a pandemic and stoc

News

US places $1.95 billion order for Pfizer/BioNTech’s COVID-19...

The US government has agreed to pay Pfizer and BioNTech $1.95 billion to secure access to 100 million doses of their coronavirus vaccine on approval, just days after promising

Views & Analysis

MSD’s David Peacock on moving UK healthcare forward

David Peacock has worked across the world for MSD and other companies, and has now taken the helm of MSD’s UK & Ireland operations.

News

Healthware's New Normal resource hub for COVID-19

Healthware launches global resource hub for COVID-19’s 'new ...

Healthware has launched a new online resource that aggregates information and analysis on how to respond to the huge changes COVID-19 has wrought across life sciences and healthcare.

News

Controversy as pharma execs predict profits from COVID-19 va...

Concerns have emerged about access to some potential COVID-19 vaccines after pharma executives from three companies said they expect to make profits from their products in evidence to a US

Coronavirus pharma news roundup – 24/07/20

Influential MPs 'astonished' at UK government's delayed pand...

US places $1.95 billion order for Pfizer/BioNTech’s COVID-19...

MSD’s David Peacock on moving UK healthcare forward

Healthware launches global resource hub for COVID-19’s 'new ...

Controversy as pharma execs predict profits from COVID-19 va...

On genomics, NGS, and doing much more good than bad, with Ma...

How to meet your physicians where they are online

Coronavirus

Editor's Picks